OPTZ:NASDAQOptimize Strategy Index ETF Analysis
Data as of 2026-04-22 - not real-time
$41.58
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The Optimize Strategy Index ETF (OPTZ) is trading at $41.58, just below its 52‑week high of $41.98 and the calculated resistance level of $41.97, while comfortably above the support zone of $34.80. Technicals are strongly bullish: the 20‑day SMA ($38.62) sits above the 50‑day SMA ($38.09) and both are well above the 200‑day SMA ($35.72), the MACD line is positive and crossing its signal, and the RSI is at 73, indicating momentum but also a near‑overbought condition. Volume is increasing despite modest absolute levels, and the fund shows a robust YTD return of 48.9% amid an "Extreme Greed" market sentiment. Risk metrics reveal a beta of 1.29 and 30‑day volatility of 24.5%, with a max drawdown of just over 10%, while tracking error is zero and expense ratio remains low at 0.25%.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with strong bullish SMA alignment
- RSI approaching overbought levels
- Increasing volume supporting momentum
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Solid YTD performance (48.9% return)
- Zero tracking error and low expense ratio
- Beta above 1 suggesting upside in a rising market
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Diversified mid‑cap blend exposure
- Sustained bullish trend across multiple moving averages
- Manageable volatility relative to sector peers
Key Metrics & Analysis
Fund Metrics
Expense Ratio0.25%
AUM$208.5M
Inception Date2024-04-22
Avg Daily Volume8,050
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield0.58%
Technical Analysis
TrendBullish
RSI73.7
Support$34.80
Resistance$41.97
MA 20$38.62
MA 50$38.09
MA 200$35.72
MACDBullish
VolumeIncreasing
Fear & Greed Index87.05
Risk Assessment
Beta1.29
Volatility24.50%
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.